by Joel Rothman | Aug 31, 2009 | NutriSupLaw
This is a tale of two types of weight-loss products and how the Food and Drug Administration had different responses to similar problems with them. The separate, but not equivalent treatment raises questions about how the FDA operates. On Aug. 24, the FDA issued a...
by Joel Rothman | Aug 26, 2009 | NutriSupLaw
Financiers have discovered what the industry knew all along: Economic hard times have not been bad for makers and sellers of wellness products. People are willing to forgo luxuries, even new cars and homes, but not their health. As a result, the supplement industry...
by Joel Rothman | Aug 23, 2009 | NutriSupLaw
GUEST POST by Jennifer Diaz The United States Food and Drug Administration (FDA) has authority to put an importer, manufacturer, shipper, grower, geographic area of a country, or an entire country on a “detention without physical examination” (DWPE) list (a/k/a the...
by Joel Rothman | Aug 19, 2009 | NutriSupLaw
GUEST POST by David A. Mark Placebos don’t work when you are asleep. Or if you have Alzheimer’s disease. But they do seem to make a difference in research and clinical practice, as I found when preparing a recent article for Nutraceuticals World. In clinical trials...
by Joel Rothman | Aug 11, 2009 | NutriSupLaw
Following reports in the Washington Post that standards for classifying foods as organic had been relaxed, the U.S. Agriculture Department is launching an audit of its National Organic Program. The Post says that department thinks external scrutiny is needed to...